This presentation will cover the principles and intricacies of the jet milling process. It will also highlight some of the challenges when micronizing for inhalation delivery, and give some possible solutions.
A case study will demonstrate a reliable process development strategy using a QbD approach for micronizing nilotinib, an API with potential for the treatment of severe chronic asthma. It will highlight the significance of implementing a QbD approach, and its benefits in process development.
Overall, this presentation aims to provide valuable insights into the jet milling process and QbD approach for inhalation drug delivery and their potential applications in drug development.
- This presentation aims to provide an in-depth understanding of the jet milling process, and the significance of implementing a Quality by Design approach.
- It will address the intricacies of developing micronization processes as a particle engineering technology for inhalation.
- A case study will be presented to illustrate a reliable process development strategy that ensures all quality-critical attributes are maintained.